SC 13G Filing

Company

RIGEL PHARMACEUTICALS INC

Filed

September 22, 2022

Accession Number

0001273087-22-000109

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →